United States Cellular (USM) shares ended the last trading session 7.2% higher at $62.95. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...
Normothermic regional perfusion is an effective method for aiding in organ viability and for expanding the donor organ supply but raises ethical concerns.
U.S. Cellular's stock climbed 11% midday Friday. "U.S. Cellular Shares Climb 14% on Deals for Spectrum Assets," at 11:17 a.m. ET, misstated the percentage change in the headline.